https://www.selleckchem.com/pr....oducts/Vorinostat-sa
The key N6 methyladenosine (m6 A) RNA methylation regulator is associated with multiple tumor progression. However, the m6 A-associated regulators that influence non-small-cell lung cancer (NSCLC) development have not been fully clarified. The m6 A regulator expression pattern of NSCLC patients from the TCGA dataset was identified. Aberrations of m6A modulators are related to NSCLC development via cBioPortal database. Furthermore, we found that IGF2BP2, IGF2BP3, HNRNPA2B1, and FTO are significantly correlated with advanced stage
Like
Comment
Share
